SCHEMBL183203

SCHEMBL183203

CC(=O)C=Cc1ccc(C)o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 1.00
MAPT P10636 10/20 1.00
KMT2A Q03164 4/20 1.00
MEN1 O00255 3/20 1.00
KDM4E B2RXH2 5/20 0.69
HTT P42858 4/20 0.69
PKM P14618 1/20 0.69
SMN1; SMN2 Q16637 6/20 0.56
TP53 P04637 2/20 0.56
HPGD P15428 6/20 0.54
RAB9A P51151 7/20 0.53
TDP1 Q9NUW8 3/20 0.53
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
NPC1 O15118 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14793134 1.00 ALDH1A1 (1.00) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL2720407 0.84 MAPT (0.74) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL2720405 0.84 MAPT (0.74) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL7891174 0.82 ALDH1A1 (0.70) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL7891168 0.82 ALDH1A1 (0.70) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL7138908 0.82 MAPT (0.69) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL17705171 0.79 ALDH1A1 (0.66) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL8824423 0.79 ALDH1A1 (0.66) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL8824451 0.79 ALDH1A1 (0.66) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL19261731 0.79 MAPT (0.65) ALDH1A1MAPTKMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884944-B2 Remendable interfaces for polymer composites DREXEL UNIVERSITY (US) 2018-02-06 US claimed
WO-2011096812-A1 METHOD AND APPARATUS FOR MODIFYING WOOD, AND WOOD PRODUCT VIA INGENIO B.V. (NL) 2011-08-11 WO claimed
EP-2035198-A1 METHOD FOR MODIFYING WOOD AND WOOD THEREBY OBTAINED Transfurans Chemicals (BE) 2009-03-18 EP claimed
WO-2007147804-A1 METHOD FOR MODIFYING WOOD AND WOOD THEREBY OBTAINED TRANSFURANS CHEMICALS (BE) 2007-12-27 WO claimed
US-20240131499-A1 BIOMIMETIC CATALYSTS FOR DIVERSE INDUSTRIAL APPLICATIONS IN CHEMICAL REACTIONS U.S. DEPARTMENT OF ENERGY 2024-04-25 US disclosed
EP-3902891-A1 METHODS AND COMPOSITIONS FOR CONTROLLING EXCESS WATER PRODUCTION Saudi Arabian Oil Company (SA) 2021-11-03 EP disclosed
WO-2020146885-A1 METHODS AND COMPOSITIONS FOR CONTROLLING EXCESS WATER PRODUCTION SAUDI ARABIAN OIL COMPANY (SA) 2020-07-16 WO disclosed
US-20200224078-A1 METHODS AND COMPOSITIONS FOR CONTROLLING EXCESS WATER PRODUCTION SAUDI ARABIAN OIL COMPANY (SA) 2020-07-16 US disclosed
US-9884944-B2 Remendable interfaces for polymer composites DREXEL UNIVERSITY (US) 2018-02-06 US disclosed
US-20130295399-A1 BIOCOMPOSITE PANEL RESOPAL GMBH (DE) 2013-11-07 US disclosed
US-20130059988-A1 REMENDABLE INTERFACES FOR POLYMER COMPOSITES DREXEL UNIVERSITY (US) 2013-03-07 US disclosed
US-8158206-B2 Method for modifying wood and wood thereby obtained TRANSFURANS CHEMICALS (BE) 2012-04-17 US disclosed
EP-0651732-A1 EMULSIFIED FURAN RESIN BASED GLASS FIBER BINDING COMPOSITIONS AND PROCESS OF BINDING GLASS FIBERS Schuller International, Inc. (US) 1995-05-10 EP disclosed
EP-0642476-A1 GLASS FIBER BINDING COMPOSITIONS, PROCESS OF BINDING GLASS FIBERS, AND GLASS FIBER COMPOSITIONS. SCHULLER INT INC (US) 1995-03-15 EP disclosed
WO-1994026676-A1 GLASS FIBER BINDING COMPOSITIONS, PROCESS OF MAKING GLASS FIBER BINDING COMPOSITIONS AND PROCESS OF BINDING GLASS FIBERS SCHULLER INTERNATIONAL, INC. (US) 1994-11-24 WO disclosed
WO-1994026677-A1 EMULSIFIED FURAN RESIN BASED GLASS FIBER BINDING COMPOSITIONS AND PROCESS OF BINDING GLASS FIBERS SCHULLER INTERNATIONAL, INC. (US) 1994-11-24 WO disclosed
WO-1994026798-A1 LOW VOC FURAN RESINS AND METHOD OF REDUCING VOCs IN FURAN RESINS SCHULLER INTERNATIONAL, INC. (US) 1994-11-24 WO disclosed
WO-1993025490-A2 GLASS FIBER BINDING COMPOSITIONS, PROCESS OF BINDING GLASS FIBERS, AND GLASS FIBER COMPOSITIONS SCHULLER INTERNATIONAL, INC. (US) 1993-12-23 WO disclosed
US-5112848-A Antiasthmatics and antiarthritic agents ABBOTT LABORATORIES (US) 1992-05-12 US disclosed
EP-0320628-A1 Substituted furan compounds which are useful in inhibiting lipoxygenase enzymes, particularly 5-lipoxygenase ABBOTT LABORATORIES (US) 1989-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240131499-A1 BIOMIMETIC CATALYSTS FOR DIVERSE INDUSTRIAL APPLICATIONS IN CHEMICAL REACTIONS LDHA, AGL, GLUL ALDH1A1 154/4885MAPT 1418/4885KMT2A 1500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.